Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Unlike most other ASX 200 blue chips, CSL is not known for its dividends
  • But even so, this company has a strong record when it comes to increasing its payouts
  • So here's all you need to know about the next CSL dividend

Perhaps uniquely amongst the top shares of the S&P/ASX 200 Index (ASX: XJO), healthcare giant CSL Ltd (ASX: CSL) is not well known for its dividend payments.

That's because, unlike the big four banks, and the likes of BHP Group Ltd (ASX: BHP), Rio Tinto Limited (ASX: RIO), and Telstra Group Ltd (ASX: TLS), the CSL dividend yield doesn't often get above 1%.

Yet CSL still has a long and proud history of paying dividends to its shareholders. In fact, it has upped its dividend quite substantially over the past few years. Back in 2019, investors enjoyed $2.66 in annual dividends per share. But in 2022, this had ratcheted up to $3.18 per share.

This trend seems to be continuing in 2023. CSL's next interim dividend, and its first for the year, is due on 5 April next month and will come in at US$1.07 per share, unfranked. That's a decent 2.88% increase over 2022's interim dividend of US$1.04 cents per share.

an older couple look happy as they sit at a laptop computer in their home.

Image source: Getty Images

You'd better be quick if you want the next CSL dividend

But if you wish to collect this latest dividend from the blood plasma and vaccine company, you'd better be quick. That's because CSL is scheduled to trade ex-dividend for this next payment in just two days' time. Yes, CSL will 'go ex-div' for its next interim dividend on 9 March – this Thursday.

When a company trades ex-dividend, it cuts off any new investors from receiving its latest dividend payment. So anyone who owns CSL shares by the close of tomorrow's trading session will receive the company's upcoming dividend payment. But anyone who buys CSL shares from Thursday onwards will not.

Because of this, we can expect to see a bit of a drop in the CSL share price on Thursday morning. This will reflect the fact that CSL shares will become slightly less viable on Thursday, seeing as the shares will no longer come with the right to receive this latest dividend.

This is what typically happens when an ASX divided share passes its ex-dividend date.

So, as you might have gathered, CSL denominates its dividend payments in US dollars.

The raw amount of US$1.07 per share has been fixed, but ASX investors will only find out exactly how much is coming their way in Australian dollar terms on 10 March, this Friday. On today's exchange rates though, it will be around $1.59 per share.

Then, it's less than a month until dividend payday on 5 April.

At today's pricing, CSL shares are up 4.31% in 2023 so far:

At this share price, CSL shares now have a dividend yield of 0.96%.

Motley Fool contributor Sebastian Bowen has positions in Telstra Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Are Cogsgate shares a buy, hold or sell after rocketing 12% higher yesterday?

This broker thinks there could be more growth to come.

Read more »

woman in lab coat conducting testing.
Healthcare Shares

Is this battered ASX biotech stock ready to rocket higher?

Brokers are upbeat and see upside of up to 125%!

Read more »

young female doctor with digital tablet looking confused.
Healthcare Shares

Why are CSL shares struggling to regain momentum?

Analysts have widely considered the shares to be oversold for some time now.

Read more »

Happy man working on his laptop.
Healthcare Shares

This ASX healthcare stock is up 70% in a year and climbing again today

Another strong quarter keeps the Cogstate stock in focus.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX healthcare stock could more than double according to Canaccord Genuity

It's shaping up as a big year for this drug developer.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Healthcare Shares

Why Neuren shares are rebounding on Wednesday after a brutal 2026 sell-off

Neuren shares jump after DAYBUE STIX expands across the US.

Read more »